Search Results 151-160 of 16195 for GLP-1 agonist

  1. Glyburide (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Acebutolol; Aminolevulinic Acid ...

  2. Insulin glargine-yfgn, recombinant (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy.

  3. Measuring Glucagon Kinetics in Humans - Clinical Trials

    Participation eligibility · Any medication other than insulin, being taken to lower blood glucose, such as Pramlintide, Metformin, GLP-1 Analogs such as ...

  4. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    * GLP-1 RA including dual peptide agonists and related molecules (e.g., GLP-1/GIP RA), * DPP-4i, * TZDs, * SGLT2is, * SUs, * Meglitinides, * Insulin (basal ...

  5. Insulin glargine and lixisenatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy.

  6. Pioglitazone and metformin (oral route) - Side effects & dosage - Mayo Clinic

    This medicine does not help patients who have insulin-dependent or type 1 diabetes. This medicine is available only with your doctor's prescription. This ...

  7. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

    Diagnosed with type 1 diabetes. History of diabetic ketoacidosis or ... Discontinuation of a GLP-1RA or a GLP-1/GIP dual-agonist within 6 months of ...

  8. Dasiglucagon (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Back to top ...

  9. Publications - Philip M. Jones, M.D. - Mayo Clinic

    2024 Nov 1; 52 (11):1661-1673 Epub 2024 Sept 18. View PubMed; Jones PM, Hobai IA. Glucagon-Like Peptide 1 Receptor Agonist Use Before Surgery. JAMA Surg. 2024 ...

  10. Ertugliflozin and sitagliptin (oral route) - Side effects & dosage - Mayo Clinic

    This medicine does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use insulin injections. This medicine is ...